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OBJECTIVES: To measure the prevalence of, and to
establish predictors for, the nasal carriage of methicillin-
resistant Staphylococcus aureus (MRSA) at hospital admis-
sion. To evaluate mannitol-salt agar with oxacillin for the
simultaneous detection and identification of MRSA from
nasal swabs.
DESIGN: Three-month prospective case-control
survey, with data collected from interviews and computer-
ized databases. The criterion standard for MRSA detection
was culture on Mueller-Hinton agar with oxacillin 6 µg/mL
(National Committee for Clinical Laboratory Standards
method).
SETTING: 320-bed tertiary-care hospital.
PATIENTS: 387 patients screened within 24 hours
after admission, including 10 MRSA carriers (cases), 291
patients with no S aureus, and 86 patients with methicillin-
susceptible S aureus.
RESULTS: The prevalence of MRSA nasal carriage
was 2.6%, whereas the prevalence of carriage was 3.1%
when both nasal and wound cultures were performed. The
significant predictors of carriage were a prior detection of
MRSA, open wounds, diabetes mellitus, treatments by
injection, prior nursing home stays, visits at home by a
nurse, and prior antibiotic treatments. Cases had stayed for
longer periods in hospitals and had received longer antibi-
otic treatments within a year. Eighty patients (including the
10 cases) had diabetes, had been exposed to healthcare
facilities within a year, and had antibiotics within 6 months.
The sensitivity and negative predictive value of nasal swabs
on mannitol-salt agar with oxacillin were 60% and 71%,
respectively.
CONCLUSION: MRSA carriage on admission to
the hospital may be an increasing and underestimated
problem. Further studies are needed to develop and vali-
date a sensitive and specific prediction rule (Infect Control
Hosp Epidemiol 1998;19:181-185).
The threat of methicillin-resistant Staphylococcus
aureus (MRSA) in hospitals was recognized first in
Europe and the United States in the late 1960s.1,2
Nowadays, MRSA has been detected worldwide and
accounts for a growing proportion of S aureus isolated
from hospitalized patients in many countries.3-5
Mulligan and colleagues, in their comprehen-
sive review, remind us that “there are two major
mechanisms for the introduction of MRSA into an
institution: the most common is the admission of an
infected or colonized patient who serves as a reser-
voir; less frequent is the arrival of a colonized or
infected healthcare worker who disseminates the
organism directly”.6
Until recently, index cases were thought to
have acquired MRSA in another hospital or a nursing
home, with the exception of rare community-
acquired outbreaks that occurred mainly among
intravenous drug users.7 The described risk factors
for the nosocomial acquisition of MRSA are a long
hospital stay, numerous or prolonged antibiotic
courses, the presence of invasive devices, or proxim-
ity to an already infected or colonized inpatient.8
Since then, and secondary to recent trends in
health care, concerns arose about the potential spread
of MRSA to the community.9 In three recent reports
on the epidemiology of MRSA at institutions in
Canada, Switzerland, and the United States, 20% to 62%
of patients colonized with this organism were detected
within 48 to 72 hours after admission.10-12 A substan-
tial proportion of these patients presented no known
risk factors for MRSA carriage. However, these stud-
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ies were descriptive and did not explore systematical-
ly past exposures to the healthcare system.
We designed this study to determine the preva-
lence of MRSA carriage on admission to our hospital
and to establish predictors for such a carriage. A sec-
ondary goal was to evaluate mannitol-salt agar with
oxacillin 4 µg/mL for the simultaneous detection and
identification of MRSA from nasal swabs.
METHODS
The Deaconess Hospital is a 320-bed, tertiary-
care, urban, teaching hospital with approximately
10,000 admissions per year. The routine surveillance
for MRSA at this institution is laboratory-based. In
1995, 18% (201/1,116) of the patients with clinical cul-
tures positive for S aureus were colonized or infected
with MRSA, of whom 113 (56%) were new or incident
cases. Only 43 of the latter (38%) were considered as
nosocomial. The remaining 62% were detected with-
in the first 72 hours of their hospital stay or were out-
patients.
After approval by the Institutional Review
Board, surveillance cultures were performed, in a
nonepidemic setting, from September 25 to
December 23, 1996, on two wards chosen to reflect a
large proportion of our hospital’s activities. Ward A
admits mostly patients for vascular surgery and podi-
atry; ward B admits patients for general medicine
and general surgery. Weekly, from Monday through
Thursday, patients who had been admitted within
the past 24 hours and had not been identified already
as MRSA carriers within this study were asked to
participate.
Nasal cultures were collected from every con-
senting patient by using moistened rayon swabs
(Starswab; Starplex Scientific, Gormley, Ontario,
Canada) rotated five times in both anterior nares.
The samples were carried within 2 hours to the labo-
ratory and processed according to a method adapted
from Lally and colleagues.13 Briefly, swabs were kept
overnight at 35ºC in an enrichment tryptic soy broth
with 7.5% NaCl and later plated onto mannitol-salt
agar with and without 4 µg/mL of oxacillin (Remel,
Lenexa, KS). The plates (two per patient) were incu-
bated at 35ºC with 5% CO2 for 24 hours. Patients with
mannitol-fermenting, coagulase-positive colonies
growing only on the plate without oxacillin were con-
sidered carriers of methicillin-susceptible S aureus
(MSSA). Those with growth of such colonies on both
plates were considered MRSA carriers. All S aureus
isolates subsequently were screened for methicillin
resistance on Mueller-Hinton agar supplemented
with salt and oxacillin 6 µg/mL, according to National
Committee for Clinical Laboratory Standards
(NCCLS) guidelines.14 The sensitivity, specificity,
and negative predictive value of mannitol-salt agar
with oxacillin were calculated, the NCCLS method
being considered the criterion standard.
Wound swabs, when available, were processed
routinely by the laboratory and plated directly onto
sheep blood agar. S aureus growing from these cul-
tures were screened for methicillin resistance
according to the NCCLS guidelines, as above.14
A case-control study was implemented to estab-
lish predictors for the nasal carriage of MRSA on
admission. Cases were patients with nasal cultures
positive for MRSA. A first control group consisted of
patients with no S aureus isolated from their nares.
Patients with nares cultures that yielded only MSSA
constituted a second control group.
Initially, interviews were administered after
cases and controls had been identified. From
October 16, all patients were asked five questions at
the time the nasal swabs were collected. They were
queried regarding the presence of an open wound,
the time elapsed since their last hospital stay, last
nursing home stay, last antibiotic treatment, and last
outpatient visit to a hospital. Additional information
collected by written questionnaires included the pres-
ence of invasive devices on admission, ambulatory
dialysis, treatments by means of injections, and com-
munity exposures to healthcare workers or other per-
sons at risk for MRSA carriage. Most exposures were
considered for as far back as 5 years. Information on
underlying diseases was collected from the hospital
administrative database by using Access (Microsoft,
Redmond, WA). Comorbidities were weighted
according to the Charlson score.15 Variables that
were associated significantly with MRSA carriage
were used to develop a preliminary prediction rule.
Data were entered in Epi Info (Centers for
Disease Control and Prevention, Atlanta, GA, and
World Health Organization, Geneva, Switzerland) and
analyzed in SAS (SAS Institute, Cary, NC).
Differences in proportions and means between cases
and controls were tested by Fisher’s Exact Tests, two-
sample t tests, or Wilcoxon Rank Sum Tests, as appro-
priate. All tests were two-tailed; P<.05 was considered
significant. To calculate a limiting odds ratio (OR) in
cases where the numerator of a given proportion
(rate) either was zero or equalled the denominator
(which would result in an empty cell in a two-by-two
table, preventing calculation of the OR), the calcula-
tion was performed based on the next less extreme
distribution, in which the numerator equalled one, or
one less than the denominator, respectively, and the
result is shown as greater than (or less than, if appro-
priate) the OR calculated thereby.
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RESULTS
There were 746 eligible admissions to wards A
and B during the study period, of whom 412 were
asked for consent, and 387 agreed to participate in
the study. Mean age was 58.2 years (range, 17-93);
164 were females and 223 males.
S aureus was recovered from nasal swabs taken
from 96 patients (24.8%), of whom 6 were colonized
by MRSA as determined on mannitol salt screening.
However, subsequent evaluation of the 96 isolates on
Mueller-Hinton media supplemented with NaCl and
oxacillin 6 µg/mL (NCCLS method) disclosed 4 addi-
tional MRSA that previously had been misidentified
as MSSA. Thus, the prevalence of MRSA and MSSA
nasal carriage on admission was 10 of 387 (2.6%) and
86 of 387 (22.2%), respectively.
When the NCCLS method was considered the
gold standard, the sensitivity of mannitol-salt agar
with oxacillin was 60%, its specificity was 100%, and its
negative predictive value was 71% (Table 1).
Of the 387 admissions, 314 were queried for the
presence of an open wound. Of 95 with an open
wound, 71 had cultures obtained within 24 hours
after hospital admission. These 71 wound cultures
revealed no S aureus in 43 (60.6%), MSSA in 22 (31%),
and MRSA in 6 (8.4%), of whom 5 also had nasal cul-
tures positive for MRSA and 1 had no S aureus in the
nares. Thus, of 290 patients with either no open
wound or wounds from which cultures were
obtained, 9 (3.1%) carried MRSA at the time of hospi-
tal admission in their nares, a wound, or at both sites.
To define the features of patients who carry
MRSA, the 10 patients from whom nasal swab cul-
tures yielded MRSA (cases) were compared to the
291 patients with no S aureus isolated from nares and
to the 86 patients with MSSA isolated from nares.
The significant differences between these groups are
given in Table 2. Cases were more likely than
patients in either control group to have been detect-
ed previously as MRSA carriers and to suffer from an
open wound and from diabetes. They also had been
hospitalized for longer periods of time during the
past year and were more likely to have been resi-
dents in chronic-care facilities and visited by a health-
care worker at home within the past year. Cases also
were more likely to have received antibiotics within
the past 6 months and to have received them for
longer periods. They were more likely than patients
with MSSA to be treated by means of injections. No
significant differences were found between cases and
either control group for age, gender, various underly-
ing conditions other than diabetes or the presence of
an open wound, Charlson comorbidity score, pres-
ence of invasive devices, undergoing dialysis, being
transferred from a hospital or a nursing home, or
having visited the outpatient department of a hospi-
tal. The small number of outcomes, missing values,
and “empty cells” prevented the use of multivariate
logistic regression to adjust for confounding.
Methicillin-resistant S aureus carriage in 4 of
the 10 cases had been detected during past admis-
sions, 12 days to 23 months previously, by our routine
laboratory-based surveillance system of clinical cul-
tures. Three others who had been transferred from
hospitals or nursing homes were detected early in
this admission by the same surveillance system
because routine wound cultures were ordered by
clinicians. This laboratory-based system detected
two patients much (24 and 90 days) later during their
hospitalization. One patient would not have been
detected at all in the absence of this study. Thus,
three of the six previously unknown MRSA carriers
would not have been detected on admission in the
absence of surveillance cultures. All three were
admitted from the community.
The three features of diabetes, antibiotic treat-
ment within 6 months, and exposure to a healthcare
facility within the past year were found in 80 (20.7%)
of the 387 study patients. All 10 MRSA carriers were
in this subgroup. Forty-five patients (11.6%) present-
ed with the same features plus an open wound, and
eight of the cases were among them. Thus, the first
set of features would have a sensitivity of 100% and a
specificity of 81% to detect MRSA carriage. Adding
the fourth feature to this set would result in a sensi-
tivity of 80% and a specificity of 90%.
DISCUSSION
This study revealed a prevalence of 2.6% and
3.1% for MRSA carriage among patients admitted to
an urban tertiary-care hospital, as determined by
TABLE 1
A COMPARISON OF MANNITOL-SALT AGAR WITH
OXACILLIN 4 µG/ML VERSUS MUELLER-HINTON WITH SALT
AND OXACILLIN 6 µG/ML (NCCLS METHOD) FOR THE
DETECTION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS
AUREUS
Mannitol-Salt
MRSA MSSA
NCCLS method MRSA 6 4 10
MSSA 0 86 86
Total 6 90 96
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA,
methicillin-susceptible S aureus; NCCLS, National Committee for Clinical
Laboratory Standards.
P=.045 (McNemar’s Test).
https://doi.org/10.2307/30143438
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 11:20:39, subject to the Cambridge Core terms of use, available at https:/www.cambridge.org/core/terms.
184 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY March 1998
either nasal cultures alone or the combination of
nasal and wound cultures, respectively. In a previous
study, the sensitivity and negative predictive value of
the combination of cultures from these two sites were
100%.16 In addition, the use of enrichment broth,
which enhances the sensitivity of detection of S
aureus from nasal swabs,17 and the implementation
of two different techniques to detect methicillin resis-
tance in our isolates should have prevented most
false-negative results. On the other hand, the large
proportion of patients with open wounds in our popu-
lation could have influenced our results. Indeed, we
found, as previously suggested by others,18 that
MRSA was associated significantly with skin defects.
This prevalence of MRSA carriage is approxi-
mately twice that found by Walsh and colleagues
approximately 10 years ago among 253 patients
admitted to the Veterans’ Administration Medical
Center in Baltimore.19 Besides differences in meth-
ods or populations, this difference could be due to
changing habits in healthcare over the past decade.
Once seen as merely an epidemic nosocomial
pathogen, MRSA has become endemic in most insti-
tutions and could be spreading to the community,
because the barriers between both settings are less
evident nowadays than they were in the past.20
In the absence of admission surveillance, 50% of
previously unknown MRSA carriers would have been
missed or detected late. Thus, the continuous intro-
duction of MRSA into tertiary-care institutions
through colonized patients admitted from the com-
munity may be an important and underestimated fac-
tor in the epidemiology of nosocomial infections due
to this microorganism.
Descriptive studies have mentioned the lack of
evident risk factors in some inpatients from whom
MRSA was detected early after admission.10-12 We
addressed this issue prospectively by taking a care-
ful medical history and by designing a case-control
survey. We found that MRSA carriage, in contrast to
the carriage of MSSA, was significantly associated
with variables reflecting contacts with the healthcare
system. All of our 10 cases had exposure to an acute-
or a chronic-care facility, hospitals or nursing homes,
or visits to a hospital outpatient department, within
the past year.
Although community acquisition of MRSA has
been reported and may be an emerging threat,21,22
this term could be overused and misleading. Our
results suggest that “community carriage” is a more
appropriate term, because the acquisition of MRSA
still might take place primarily in healthcare institu-
tions, with carriage persisting in the community forTA
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years.16 Causal inferences, however, should be
drawn from our data with caution, because the time
relationships between MRSA carriage (the outcome)
and exposures to the healthcare system remain
unknown, and because confounding could not be
excluded by adjusted analysis.
The predictors associated with MRSA carriage
at the time of admission, while not establishing a
causal relationship, still may be used to identify
appropriate patients for selective surveillance and
the early implementation of cost-effective infection
control measures. Our data suggest that, in addition
to patients known to have been MRSA carriers in the
past, patients who suffer from diabetes, who have
been exposed to a healthcare facility during the past
year and have received antibiotics within the past 6
months are appropriate targets for selective cultures
on admission. Cultures should include the nares and
any wound. Further studies are needed, however, to
develop a more precise prediction rule by using mul-
tivariate analysis. Additionally, sensitive and specific
techniques that allow rapid identification of MRSA
are needed.
In conclusion, the prevalence of MRSA carriage
upon admission to the hospital appears to have
increased during the past decade. Although most
patients still may acquire MRSA in healthcare facili-
ties, the continued community carriage of these
organisms mandates additional study of this phe-
nomenon and potentially new approaches to infection
control. Finally, it is likely that similar patterns of car-
riage exist for other nosocomially acquired organ-
isms, such as vancomycin-resistant enterococci and
Clostridium difficile, and that analogous investiga-
tions should be focused in these areas.
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